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Background: Due to low success rates, periprocedural complications and higher
risk for restenosis the recanalization of chronic total occlusions of coronary ar-
teries (CTO) remain a challenging task in interventional cardiology. Furthermore
several studies have revealed that restenosis and late stent thrombosis are linked to
the polymer layer of drug eluting stents. We therefore tested whether drug eluting
stents with completely biodegradable polymers are applicable for the treatment of
CTO’s.
Methods: In order to test this hypothesis we retrospectively examined in a mono-
centric analysis data of 102 CTO patients who were exclusively treated with biolimus
eluting stents with fully biodegradable polymers in the past 24 months. CTO was
deﬁned as total occlusion of a coronary artery for more than 3 months and TIMI 0 ﬂow
in the occluded segment. Primary study endpoint was late loss at the initial occlusion
site after 6 months. Secondary clinical endpoints included a composite of cardiac
death, myocardial infarction and target vessel revascularization after 6 months
(MACE).
Results: 170 CTO procedures were performed in the past 24 months. 138 CTO’s
were successfully reopened which corresponded to a success rate of 81%. The mean
occlusion length of 24  14 mm was treated with an average stent length of 68  30
mm. J-CTO score was 1,8  0,9. 102 of the successfully recanalized CTO patients
received biolimus eluting stents with biodegradable polymers. Meanwhile 78 pa-
tients have concluded angiographic and clinical 6 months follow up. Late loss at the
initial occlusion site was 0,26  0,56 mm. Binary restenosis with the need for
reintervention occurred only in 5 patients (6,4%). Cardiac death was documented in
1 patient. In addition to that, one patient suffered from a stent thrombosis with a
consecutive myocardial infarction during follow up. Therefore the MACE rate was
calculated with 9%.
Conclusions: First results of our monocentric analysis indicate that biolimus eluting
stents with fully biodegradable polymers are associated with little late loss and low
MACE rates in complex CTO lesions. Future studies in larger, independent patient
cohorts are necessary to conﬁrm our results.
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Background: Clinical beneﬁt in improving procedural success of a multi-slice
computed tomography (MSCT) analysis prior to CTO recanalization is unknown. We
performed a prospective randomized trial so as to assess clinical impact of MSCT in
improving immediate procedural results.
Methods: 106 eligible patients who were scheduled for percutaneous recanalization of
a true CTO (Euro-CTO deﬁnition) and without contraindications for MSCT were
included in the study (TACCTO). All patients underwent MSCT and were randomized
(1:1) to be or not to be aware of the result of the MSCT prior to CTO recanalization.
MSCT versus conventional coronary angiography (CCA) group were compared
regarding immediate procedural success. By protocol, same 10 CTO CCA and MSCT-
angiography characteristics (based on previously published independent predictors of
CTO failure) were pre-deﬁned to be independently analysed. In the MSCT group, CT-
scan analysis was open to the operator prior to the procedure. A 256-detector system
was used for all studies. Post processing was performed with speciﬁc software.
Results: The mean age was 62  10 years old. According to the Japanese-CTO score
of complexity 51% of lesions were classiﬁed as difﬁcult or very difﬁcult. 52% were
calciﬁed lesions and RCA was the most frequent lesion treated. In most cases (88%)
the strategy was anterograde. The total stent length implanted per lesion was of 51.6
20.3mm. In all case last generation DES was implanted. Technical success was
achieved in 86.8% of the patients in the MSCT group and 84.9% of those in the CCA
group (p¼0.75). According to the J-CTO score 2 subgroups of complexity were done:
a) easy-intermediate and b) difﬁcult-very difﬁcult. In sub-group a), procedural success
was achieved in 100% in both groups (MSCT and CCA). In sub-group b), procedural
success was achieved in 80% of the patients in the MSCT group and 75.7% of those in
the CCA group (p¼0.85).
Conclusions: According with the results of this prospective randomized trial, in our
current era, with new CTO material and techniques, it seems that the information
provided by MSCT could be useful, but did not provide a signiﬁcant impact in pro-
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Background: This study sought to investigate predictive factors of ﬁnal PCI proce-
dural success in patients with LAD-CTO compared to patients with nLAD-CTO
Methods: A total of 1,657 patients who underwent 1,819 CTO-PCI at ICPS between
January 2004 and December 2013 were included in the study. Clinical, angiographic,
technical, procedural characteristics and adverse events occurring within 24 hrs were
prospectively collected. Procedural success was deﬁned as a ﬁnal diameter stenosis <
30% and TIMI ﬂow 3. Predictors of PCI success in LAD-CTO vs nLAD-CTO, were
analyzed by univariable and multivariable analysis. Early (< 24 hrs) events were recorded.
Results: The overall procedural success rate was 72.4%. Of 1,819 procedures, 542
(29.7%) were LAD-CTO-PCI. LAD-CTO-PCI had a higher procedural success rate
compared to nLAD (78.8% vs 69.7%, p< 0.0001). By logistic regression analysis,
including clinical and angiographic variables, severe CTO calciﬁcation (OR 0.46,
95%CI 0.24-0.87; nLAD: 0.35, 95%CI 0.23-0.52) , lesion length 20 mm (OR 0.55,
95%CI 0.35-0.87; nLAD OR 0.45, 95%CI 0.35-0.58), previous CABG (OR 0.1, 95%
CI 0.04-0.27; OR 0.61, 95%CI 0.40-0.93) and previous MI (0.58 95%CI 0.34-0.96;
nLAD: OR 0.69, 95%CI 0.5-0.93) were associated with a lower procedural success
rate both in LAD and in nLAD subgroups. Lesion tortuosity was an independent
predictor of PCI failure exclusively in the LAD-CTO group (OR 0.41 95%CI 0.18-
0.93), while a blunt morphology was independently correlated to lower procedural
success in the nLAD-CTO group (OR 0.58, 95%CI 0.44-0.75). No differences in
terms of death, myocardial infarction and urgent pericardiocentesis within 24 hours
were recorded between the two groups.
Conclusions: Both in the LAD-CTO-PCI and nLAD-CTO-PCI subgroup, severe
CTO calciﬁcation, lesion length, previous CABG and previous MI were predictors of
procedural success. Interestingly, lesion tortuosity and blunt stump were indepen-
dently correlated to lower procedural success in the LAD-CTO and in the nLAD-CTO
subgroup, respectively.
TCT-220
Impact of chronic total occlusion localization on 12-month mortality in patients
with non-ST segment elevation myocardial infarction treated with percutaneous
coronary intervention
Pawel Gasior1, Michal Hawranek1, Mateusz Tajstra1, Jacek Piegza1,
Janusz Szkodzinski1, Piotr Desperak1, Cislak Aneta1, Andrzej Lekston1,
Mariusz Gasior1, Lech Polonski1
1Medical University of Silesia, Silesian Center for Heart Diseases, Zabrze, Poland
Background: The aim of the present study was to evaluate the effect of chronic total
occlusion (CTO) localization in nonifarct-related artery (IRA) on 12 months mortality in
patients with NSTEMI and multivessel coronary artery disease (MV CAD) treated with PCI
Methods: We analyzed consecutive records of 991 patients with NSTEMI and MV
CAD treated with PCI admitted to the Clinic between 2006 and 2011. The inclusion
criteria were presence of MV CAD, single CTO in non-IRA and availability of 12-
month follow up. Patients with a history or qualiﬁed to CABG during current hos-
pitalization were excluded from further analysis. Clinical characteristics, in-hospital
and 12-month outcomes of 165 patients were analyzed according to localization of
CTO in coronary angiography. Patients were divided into three groups: CTO in left
anterior descending artery (CTO LAD n¼43), CTO in left circumﬂex (CTO LCx
n¼47), CTO in right coronary artery (CTO RCA n¼75).
Results: In baseline characteristic we observed signiﬁcant differences in occurrence of
diabetes (respectively: 53,5% vs 31,9% vs 25,3 p¼0,007). In-hospital mortality was
signiﬁcantly higher in CTO RCA group (respectively:2.3% vs 0.0% vs 9.3%
p¼0.044). The rates of myocardial re-infarction, target vessel revascularization,
stroke, major bleeding and average GRACE score during the hospitalization were
similar in all analyzed groups. CTO in RCA was associated with increased 12 months
mortality in studied groups (respectively: 13.9% vs 4.3 % vs 22.7% p¼0.022), post
hoc analysis showed signiﬁcant difference between CTO RCA and CTO LCx groups
(P¼0,006). In multivariate analysis CTO localized in RCA remained independent
factor inﬂuencing 12 month mortality (HR: 3,82; 95%CI: 1,58-9,20; p:< 0,003).
Conclusions: In studied population localization of CTO in RCA was associated with
worse clinical outcomes and was an independent predictor of 12 month mortalityj September 13–17, 2014 j TCT Abstracts/Coronary Lesions - CTO
